Back to results
US 7,452,527 B2Granted
Methods of promoting hair growth
AssigneeMurad, Inc.
InventorHoward Murad
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of promoting hair growth in a patient. The method comprises administering to a patient in need thereof a sugar compound that is converted to a glycosaminoglycan in the patient, a primary antioxidant component, at least one amino acid component, and one or more transition metals.
Claims9
A method of promoting hair growth, which comprises:
- identifying an individual suffering from hair loss, and
- administering to the individual an effective amount for promoting hair growth of a composition comprising:
- (1) a sugar compound that is converted to a glycosaminoglycan in the patient;
- (2) a primary antioxidant component;
- (3) at least one amino acid component;
- and
- (4) at least one transition metal component,
- wherein the sugar compound is administered at a dose of from about 40 mg to about 2500 mg per day;
- the primary antioxidant is administered at a dose of from about 40 mg to about 2400 mg per day;
- the amino acid is administered at a dose of from about 35 mg to about 1200 mg per day;
- and the transition metal component is administered at a dose of from about 4.1 mg to about 740 mg per day,
- wherein the sugar compound and primary antioxidant component and at least one amino acid component and at least one transition metal component are administered simultaneously.
9 more elements
A method of promoting hair growth, which comprises:
- identifying an individual suffering from hair loss, and
- administering to the individual an effective amount for promoting hair growth of a composition comprising:
- (1) a sugar compound that is converted to a glycosaminoglycan in the patient;
- (2) a primary antioxidant component;
- (3) at least one amino acid component;
- and
- (4) at least one transition metal component,
- wherein the sugar compound that is converted to a glycosaminoglycan in the patient;
- the primary antioxidant component;
- the at least one amino acid component;
- and the at least one transition metal component are administered as a pharmaceutical composition comprising:
- (1) a sugar compound that is converted to a glycosaminoglycan in the patient in an amount from about 5 to about 50 weight percent of the pharmaceutical composition;
- (2) a primary antioxidant component in an amount from about 5 to about 50 weight percent of the pharmaceutical composition;
- (3) at least one amino acid component in an amount from about 2 to about 25 weight percent of the pharmaceutical composition;
- and
- (4) at least one transition metal in an amount from about 0.5 to about 15 weight percent of the pharmaceutical composition
- wherein the sugar compound that is converted to a glycosaminoglycan in the patient is N- acetylglucosamine or a salt or ester thereof;
- the primary antioxidant component is ascorbic acid or a salt or ester thereof, the at least one amino acid is selected from the group consisting of proline, lysine, cysteine, and methionine;
- and the transition metal component is selected from the group consisting of zinc, manganese, copper, and mixtures thereof.
16 more elements
Dependencies are inferred from the claim text.